新闻|股票|评论|外汇|债券|基金|期货|黄金|银行|保险|数据|行情|信托|理财|区块链|汽车|房产|科技|视频|博客
|直播|财道
|农金

简称:复星医药 代码:600196


会计年度:2002-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
代理进出口65,401,600.0059,629,200.005,772,400.008.82
广告服务9,460,300.005,931,300.003,529,000.0037.30
其他36,252,500.008,446,800.0027,805,700.0076.70
药品制造及销售307,552,600.00220,384,000.0087,168,600.0028.34
医疗器械82,366,500.0057,472,600.0024,893,900.0030.22
营销策划及服务900,000.0050,100.00849,900.0094.43
诊断产品64,585,200.0025,581,000.0039,004,200.0060.39

会计年度:2001-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
代理进出口73,209,400.0064,146,400.009,063,000.0012.37
广告服务12,189,600.0011,379,100.00810,500.006.64
合计727,844,500.00448,858,500.00--38.33
技术转让收入37,200,000.002,361,400.0034,838,600.0093.65
其他5,027,800.00640,800.004,387,000.0087.25
医疗器械143,836,700.0099,376,300.0044,460,400.0030.91
医药及医药销售311,245,100.00227,896,100.0083,349,000.0026.77
营销策划及服务39,177,500.001,202,600.0037,974,900.0096.93
诊断产品105,958,100.0041,855,600.0064,102,500.0060.49

    9/9 转到